PlainRecalls
FDA Drug Moderate Class II Terminated

Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 100 Capsules NDC 68462-130-01; b) 500 Capsules NDC 68462-130-05

Reported: September 29, 2021 Initiated: August 27, 2021 #D-0826-2021

Product Description

Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 100 Capsules NDC 68462-130-01; b) 500 Capsules NDC 68462-130-05

Reason for Recall

CGMP Deviations

Details

Units Affected
a) 216,454 bottles; b) 2166 bottles
Distribution
Nationwide.
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 100 Capsules NDC 68462-130-01; b) 500 Capsules NDC 68462-130-05. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: a) 216,454 bottles; b) 2166 bottles.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on September 29, 2021. Severity: Moderate. Recall number: D-0826-2021.